Annotation Enrichment Analysis: An Alternative Method for Evaluating the Functional Properties of Gene Sets by Glass, Kimberly & Girvan, Michelle
 Annotation Enrichment Analysis: An Alternative Method for
Evaluating the Functional Properties of Gene Sets
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Glass, Kimberly, and Michelle Girvan. 2014. “Annotation
Enrichment Analysis: An Alternative Method for Evaluating the
Functional Properties of Gene Sets.” Scientific Reports 4 (1):
4191. doi:10.1038/srep04191.
http://dx.doi.org/10.1038/srep04191.
Published Version doi:10.1038/srep04191
Accessed February 19, 2015 3:23:12 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879797
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Annotation Enrichment Analysis: An
Alternative Method for Evaluating the
Functional Properties of Gene Sets
Kimberly Glass1,2,3 & Michelle Girvan3,4,5
1Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA, 2Department of
Biostatistics, Harvard School of Public Health, Boston, MA, USA, 3Department of Physics, University of Maryland, College Park, MD,
USA, 4Institute for Physical Science and Technology, University of Maryland, College Park, MD, USA, 5Santa Fe Institute, Santa Fe,
NM.
Gene annotation databases (compendiums maintained by the scientific community that describe the
biological functions performed by individual genes) are commonly used to evaluate the functional
properties of experimentally derived gene sets. Overlap statistics, such as Fishers Exact test (FET), are often
employed to assess these associations, but don’t account for non-uniformity in the number of genes
annotated to individual functions or the number of functions associated with individual genes.We find FET
is strongly biased toward over-estimating overlap significance if a gene set has an unusually high number of
annotations. To correct for these biases, we develop Annotation Enrichment Analysis (AEA), which
properly accounts for the non-uniformity of annotations. We show that AEA is able to identify biologically
meaningful functional enrichments that are obscured by numerous false-positive enrichment scores in FET,
and we therefore suggest it be used to more accurately assess the biological properties of gene sets.
E
valuating the functional properties of gene sets is a routine step in understanding high-throughput bio-
logical data1,2 and is commonly used both to verify that the genes implicated in a biological experiment are
functionally relevant1 and to discover unexpected shared functions between those genes3,4. Many functional
annotation databases have been developed in order to classify genes according their various roles in the cell5–9.
Among these, the Gene Ontology (GO)10,11 is one of the most widely used by many functional enrichment tools
(for example1,2,12–14) and is highly regarded both for its comprehensiveness and its unified approach for annotating
genes in different species to the same basic set of underlying functions10.
It has recently been observed that many classification databases, including the Gene Ontology, exhibit a heavy-
tailed distribution in the number of genes annotated to individual categories15. However, there has been little
investigation into how these underlying annotation properties may influence the results of functional analysis
techniques. In this work we find that traditional functional enrichment approaches spuriously identify significant
associations between functional terms inGO and random gene sets, if the number of annotationsmade to genes in
the gene set is high. We also investigate the properties of curated experimentally-derived gene signatures, i.e. sets
of genes whose combined expressed patterns are associated with specific biological conditions, and find thatmany
contain a disproportionate number of highly annotated genes. Furthermore, traditional overlap statistics report
significant associations between these signatures and randomly constructed collections of functional terms.
Consequently, we propose a scheme, called Annotation Enrichment Analysis (AEA), that evaluates the overlap
in annotations between a set of genes and the set of terms belonging to a branch of the GO hierarchy, using a
randomization protocol to build a null model. By looking at annotation overlap instead of gene overlap, our
approach takes into account the annotation properties of the GeneOntology. It effectively eliminates biases due to
database construction and highlights relevant biological functions in experimentally-defined gene signatures.We
also provide a simple analytic approximation toAEA (whichwe call AEA-A, for Annotation Enrichment Analysis
Approximation) that is able to partially compensate for the biases we find using traditional approaches.
Implementations of both AEA and AEA-A are provided at http://www.networks.umd.edu.
In this study, we primarily focus on Gene Ontology annotations associated with human genes. The Gene
Ontology10 takes the form of a directed acyclic graph (DAG) in which ‘‘child’’ functional categories (‘‘terms’’) are
subclassified under one or more other, more general categories, called ‘‘parent’’ terms. ‘‘Branches’’ in the Gene
Ontology can therefore be defined as sets of terms that contain a parent term and all of its progeny. Note that these
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branches contain overlapping sets of terms since each term can be a
descendant of multiple ancestors at each level of the DAG. Using this
structure, individual genes are annotated to various functional cat-
egories. These annotations are transitive up the hierarchy such that a
parent term will take on all the gene annotations associated with any
of its progeny16. Consequently, terms with many progeny often con-
tain many gene annotations whereas terms with few progeny gen-
erally have fewer associated genes. ‘‘Biological Process,’’ ‘‘Molecular
Function,’’ and ‘‘Cellular Component’’ are the three most general
terms in GO, defining three independent branches such that every
other term can only belong to one of these three categories. As a
consequence all genes in GO are annotated to at least one, and often
all three, of these categories.
The most widely used statistics for evaluating which functional
categories are enriched in a set of genes are based on gene counts and
include Fisher’s Exact Test, the binomial test, and the chi-squared
test17. Although these statistics vary in exact implementation, they all
rely on the same basic underlying assumption that all genes have an
equal probability of being selected under the null hypothesis. Of these
tests, Fisher’s Exact Test (FET) is the most common statistic and is
used by many of the most popular functional enrichment tools (see
Table 2 in18), and therefore we choose it to represent a ‘‘typical’’
evaluation of gene set functional enrichment. FET estimates enrich-
ment by evaluating the overlap between genes in a given experi-
mental gene set with genes annotated to a GO term. Genes in the
experimentally-derived gene set are assumed to have an equal like-
lihood of being identified, consistent with the null model of FET. By
mathematical construction FET also assumes that the genes anno-
tated to a functional term are equally likely to be identified (see
Equation 3 in the Methods section); however, because some genes
are annotated to many functional terms while others are only anno-
tated to a few, it follows that genes do not have an equal likelihood of
being identified in the context of gene functional annotations, incon-
sistent with FET’s null model. We investigate how this false assump-
tion might alter predictions made in the context of functional
enrichment analysis.
Since functional enrichment analysis often involves comparing a
gene set to all the terms in GO, multiple-hypothesis corrections are
generally applied to the results of these statistical tests18. These cor-
rections decrease the value at which a comparison between a gene set
and a GO term should be considered significant. Commonly used
multiple-hypothesis corrections include the Bonferroni, Benjamini
and the False Discovery Rate. Of these, the Bonferroni is the most
conservative and adjusts the value at which a test is considered ‘‘sig-
nificant’’ by the number of tests made19. The False Discovery Rate
(FDR) adjusts the value at which a test is considered ‘‘significant’’
based on the rank of the predicted level of significance20,21. It provides
approximately the same correction as the Bonferroni for the most
significantly-ranked p-values but will not adjust tests that are the
least-significant. It is important to note that although these correc-
tions will change the critical value of individual tests, they do not
affect the rank ordering of the results.
Results
Annotation properties of the gene ontology. To start our analysis
we downloaded information regarding gene-term annotations for
human genes from the Gene Ontology website (geneontology.org)
and used this data to construct a gene-term bipartite graph,
represented as an nG 3 nT adjacency matrix, where nG is the total
number of genes and nT is the total number of terms listed in the
annotation file. In this matrix a value of one indicates a known
connection between the corresponding gene and term, and a value
of zero indicates that the gene is not associated with that term. In this
bipartite graph many terms are only associated with a small handful
of genes, while some terms are associated with many genes. A
histogram of the ‘‘degree’’, kt, of terms (the number of genes
annotated to individual terms) reveals a heavy-tailed relationship
(Figure 1(a)). In contrast, a histogram of the ‘‘degree’’, kg, of genes
(the number of terms towhich individual genes are annotated) shows
that although some genes have many more annotations than others,
the distribution is not as heavy-tailed as the term degree distribution
(Figure 1(b)). We note that the annotation properties of the Gene
Ontology are often shared by other databases (see Supplemental
Figure S1), and therefore, we believe that the methods we develop
below, although tested using the Gene Ontology, could be applied to
functional enrichment analysis using other functional classifications.
We also point out that the ‘‘Biological Process’’ ontology contains
a significant fraction of the total annotations. Although all three
ontologies are used in functional enrichment analysis, many studies
using GO focus on this ontology, both for its size and because its
members describe dynamical processes performed by the cell. We do
the same in the following analysis. The total number of annotations
made to the ‘‘Biological Process’’ ontology is 656783, originating
from 15213 genes to 10192 terms. Consequently, the average number
of annotations made by an individual gene to this ontology is 43.2
and the average number of annotationsmade to an individual term is
64.4. These values will be useful to keep in mind, especially as we
investigate the annotation properties of gene signatures and of the
terms for which they are enriched.
Figure 1 | The cumulative degree distributions of (a) terms and (b) genes in human GO annotations. ‘‘Biological Process’’ terms make up the majority
of terms and annotations. The average number of ‘‘Biological Process’’ terms to which an individual gene is annotated is 43.2 while the average
number of annotations made to an individual term is 64.4.
www.nature.com/scientificreports
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Annotation properties influence the results of functional enrich-
ment analysis. One of our goals is to determine the effect of
annotation database properties on functional enrichment analysis.
To do this, we first created 200 random gene sets with Ng members
each, but in which we controlled the total number of annotations
(Mg) made by the member genes (for more details see Methods). In
practice, experimentally-derived sets of genes can range from only a
handful (< 10) to a few thousandmembers. In this analysis we chose
Ng 5 200 since this represents a ‘‘typical’’ gene set size.
As an initial test, we used FET to determine the enrichment of all
10192 GO terms from the ‘‘Biological Process’’ ontology in each
randomly constructed gene set. Figure 2(a) shows the results for
the subset of terms that have 200 or more unique gene annotations,
ordered based on their total number of unique gene annotations. The
trend is striking. Even though they have the same number of mem-
bers, gene sets with a higher number of annotations are more
enriched in GO terms compared to gene sets with a lower number
of annotations. Although we expect a minimum p-value across all
tests of approximately 1024, insteadwe observe that randomgene sets
with the fewest annotations have a minimum p-value around 1023,
while random gene sets with the highest annotation levels have a
minimum p-value close to 1026 (Supplemental Figure S2(a)). For
high degree gene sets, we also observe that high degree GO branches
tend to bemore significantly enriched (i.e., have lower p-values) than
low degree branches. We point out that although multiple-hypo-
thesis corrections will sufficiently raise a p-value such that either very
few or no false positives occur, these biases cannot be overcome in
this manner (see Supplemental Figure S2(b)).
In order to better interpret these results, for five of our random
gene sets (Ækæ < {21, 32, 43, 54, 65}), we directly compared the
distributions of the p-values predicted by FET to the expected dis-
tribution (evenly distributed values from zero to one). Figure 2(b)
plots, in rank order, the p-values calculated for these random gene
sets for the set of terms that contain at least one gene annotation from
a member of the given random gene set. The deep dip below the
diagonal for the the more highly-annotated gene sets demonstrates
that FET is anti-conservative for these gene sets; in addition, FET also
appears to be overly conservative for gene sets with a lower overall
annotation level. Plots using all terms are shown in Supplemental
Figure S3(a).
Annotation enrichment analysis corrects for annotation bias.
Clearly annotation properties of both gene sets and functional
categories can influence the results of functional enrichment
analysis. In order to mitigate these effects, we suggest that instead
of evaluating the overlap between genes, as is traditionally done in
Figure 2 | (a) The enrichment (measured by p-value) of 200 randomly generated gene sets in GO branches. The branches are ordered based on howmany
genes are annotated to the parent term (kt) and the gene sets are ordered based on the total the number of annotations (Mg) made by the 200 genes in that
set. Although we tested enrichment for all branches, for simplicity we only visualize the subset of branches with 200 or more unique gene annotations.
There is an obvious bias toward significant enrichment between high degree gene-set/term pairs using Fisher’s Exact Test (FET). (b) A plot of the p-values
predicted by FET as a function of rank for five of the random gene sets shows that FET is both overly conservative for low degree gene sets and anti-
conservative for high degree gene sets. (c)–(d) Analogous plots to (a) and (b) illustrating that this observed annotation bias can be correctly mitigated by
using Annotation Enrichment Analysis (AEA).
www.nature.com/scientificreports
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functional enrichment analysis, one instead considers the overlap
between the annotations made to a gene set and a branch of terms
in the Gene Ontology. To accurately capture the significance of
annotation overlap we develop a randomization scheme that
preserves the transitive annotation features of the GO DAG while
calculating the probability of obtaining a certain number of
annotations between a gene set and a GO branch. We call this
approach Annotation Enrichment Analysis (AEA) and illustrate it
in Figure 3.
In this randomization is it useful to think of the Gene Ontology as
a bipartite graph (see above). We begin by determiningMg, the total
number of annotations to a gene set,Mt, the total number of annota-
tions to the terms in a GO branch, and Mgt, the number of annota-
tions stretching between this gene set and branch. We then
determine a distribution for the expected number of co-annotations.
To do this we, simultaneously, randomly permute the order of genes
and terms while still preserving the original connections from the
GO bipartite graph. By preserving the original connections, we retain
the transitive annotation properties of the GO DAG. We then take
annotations connected to the top randomly shuffled genes until
we’ve selected Mg annotations, and annotations connected to the
top randomly shuffled terms until we’ve selected Mt annotations,
and determine ~Mgt , the number of edges in the bipartite graph that
extend between these top randomly shuffled genes and top randomly
shuffled terms. In the (fairly common) case where selecting the top
Mg/Mt annotations does not correspond to selecting a whole number
of genes/terms, we take the top number of genes/terms whose total
annotations is closest to Mg/Mt, respectively. We repeat the rando-
mization process many times in order to determine a distribution of
values for ~Mgt . We define a new p-value, pA(Mgt) which reflects
the probability that ~Mgt§Mgt :
pA Mgt
 
~P ~Mgt§Mgt
 
: ð1Þ
We determined the significance of all GO branches in our randomly
generated gene sets with AEA (using 104 randomizations), and cre-
ated a heat map of these values analogous to the one produced using
standard set-overlap statistics (Figure 2(c)). The results of AEA are
close to uniform across varying gene set degree (Figure 2(d)), dem-
onstrating that AEA works well at eliminating annotation bias.
Experimental gene signatures are often highly-annotated. One of
the most common applications of enrichment analysis is to ascertain
the functional properties of a gene ‘‘signature’’ (an experimentally
determined set of genes). Although we have demonstrated that AEA
corrects for annotation bias with randomly generated gene sets, we
also want to know how well this analysis can recapitulate biologically-
relevant results. With this in mind, we downloaded signatures as
recorded in the Gene Signatures Database (GeneSigDB)22. This
database is a manual curation of previously published gene
expression signatures, focusing primarily on cancer and stem cell
signatures23. In the following analysis we will use all 309 human
signatures from this database that contain at least 100 and less than
1000 genes that also are annotated to a term in the ‘‘Biological Process’’
ontology.
First, to assess whether annotation bias might play a role in evalu-
ating the functional properties of these gene signatures, we deter-
mined the average number of annotations made by the genes
occurring in each signature. Figure 4(a) shows the number of genes
in a signature plotted against the average level of annotation for each
signature. The expectation for a random selection of genes (the aver-
age number of annotations made by all genes – see above and
Figure 1) is shown as a red line. The plot suggests that many genes
belonging to these signatures are also more highly annotated in GO.
Almost a third (99) of the signatures have an average level of annota-
tion that is greater than any of our randomly generated gene sets and
all but four signatures have an average level of annotation greater
than expected by chance. Since we have shown that random gene sets
with these annotation levels encounter a bias in traditional functional
enrichment analysis, we believe these experimental signatures are an
appropriate biological set with which to evaluate howAEA compares
to FET when investigating and discovering the functions of genes
derived from experimental biological data.
Figure 3 | An outline of how Annotation Enrichment Analysis (AEA) calculates the significance of association between a given gene set and the
collection of terms that belong to a branch in the GO hierarchy.
www.nature.com/scientificreports
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It is common practice when evaluating the functional properties of
a gene signature to focus on a set of ‘‘top’’ categories based on p-value
rank. We investigate how different the results of AEA or FET might
appear in this context. To this end, we selected the top 10% of terms
based on their enrichment score in FET and AEA to designate as
‘‘important’’ according each to thesemeasures.We compared this list
of terms to the list of terms that are ‘‘not important’’ (in the bottom
80% of terms by rank) according to each measure. The number of
terms considered important in AEA but not by FET versus the num-
ber of terms considered important by FET but not AEA for each
signature is plotted in Figure 4(b). Complete agreement between
FET and AEA on this plot is represented by a point at (0, 0), and
complete disagreement is represented by a point at (1019, 1019). In
order to see how annotation properties influenced any differences,
we colored signatures based on the average level of annotation to
their member genes.
Figure 4(b) shows overall agreement between AEA and FET, as
many points fall fairly close to the origin and, at most, reflect only a
10% difference in identified ‘‘important’’ terms. However, annota-
tion bias is evident. In signatures containing the highest levels of
annotation, i.e. those represented by reddish marks, the terms
deemed most ‘‘important’’ by FET are more likely to be considered
‘‘unimportant’’ according to AEA, and vice versus. These results are
consistent with the previous analysis in random gene sets that
showed a bias by FET to place more significance between gene sets
and terms with a higher number of annotations (see Figure 2). It also
demonstrates that annotation bias is present when evaluating experi-
mentally-derived gene signatures and is not an artifact of how we
constructed our random gene sets.
In the supplement we also directly compare FET and AEA p-
values and observe that, in these experimental signatures, a high
annotation level is correlated with increased significance by FET
compared to AEA and vice versus (Supplemental Figure S3(c)), con-
sistent with the results shown in Figure 4(b).
Annotation enrichment analysis uncovers meaningful biological
associations. Next, we investigated the specific biology that is
highlighted using AEA and FET. For each measure, we chose
approximately forty signatures having the most significant
enrichment scores across all terms. Similarly, for each measure, we
chose forty terms having the most significant enrichment scores
across all signatures. For AEA a small number (981 out of 3149328
possible) of term-signature pairs have an estimated p-value of p ,
1026 after onemillion randomizations, therefore, when necessary, we
broke ties by the number of signatures/terms enriched in the terms/
signatures at this level. Using the selected sets of terms and signatures
and the p-values associating all pairs in these sets, we then performed
a standard hierarchical clustering analysis. The results are shown in
Figure 5.
Clustering the FET results gives rise to a weak visual segregation of
terms and signatures into groups (Figure 5(a)). These groups high-
light the relationship between the gene signatures and several
important biological processes. For example, the FET clustering
shows an enrichment of cell-cycle related processes in breast cancer
signatures24 and includes immune-related terms enriched in immune
gene signatures. These two groups, however, account for only about
half of the selected terms; the clustergram also includes a number of
functional categories related to ‘‘proteins’’ and ‘‘phosphorylation’’
that are only enriched in a small number of signatures. From this
analysis we suggest that the results of FET might be muddled by a
signal driven by annotation bias, highlighting either highly-anno-
tated signatures or more general biological processes.
In contrast, when using AEA distinct clusters of signatures and
terms emerge (Figure 5(b)). The first includes signatures from
immune-systems, lymphoma and leucocytes, and is logically also
enriched in terms such as ‘‘immune system’’ and ‘‘response to stimu-
lus’’ as well as terms related to ‘‘biological regulation’’. Interestingly,
one of the breast signatures associated with this cluster25 represents a
list of genes defined based on immune response in breast cancer and
the stem cell signature26 is from a study on patients with systemic
sclerosis, a type of autoimmune disorder. In addition, the inclusion of
a protein-kinase signature27 is interesting as MAP kinases have been
shown to play an important role in immune response28.
Another cluster is enriched in categories such as ‘‘system develop-
ment’’ and ‘‘developmental process’’ and includes several signatures
associated with stem cells or identified based on their role in cellular
differentiation. It also includes a signature of oncogenes29, as well as a
signature of homeodomain proteins, known to initiate cascades of
genes that in turn will induce cellular differentiation into tissues and
organs (e.g.30,31). The next cluster, associated primarily with breast
cancer signatures, shows a strong enrichment for terms related to the
cell cycle and cellular component organization, processes known to
be differentially regulated in breast cancer24. Finally, two lymphoma
and one viral signature that were identified based on cell proliferation
(for example, by association with Myc targeting32,33) are enriched for
terms such as ‘‘cellular metabolic process.’’ This is consistent with
expectation since there is evidence that a connection exists between
proliferation and metabolic pathways in cancer cells34,35.
Figure 4 | Annotation properties of experimental gene signatures. (a) The number of genes versus the average number of annotations made to the genes
in each signature. Genes from signatures generally contain many more GO annotations than one would expect if selecting genes randomly (red line). (b)
The number of terms that are considered important (top 10% by rank) by one of the measures (either AEA or FET), but not important (bottom 80% by
rank) by the other, plotted for each gene signature. The signatures are colored according to the average level of annotation (kavg 5 Mg/Ng).
www.nature.com/scientificreports
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Somepredictionsmade by FET are likely a consequence of annota-
tion bias in experimental gene signatures.Next, we created random
term sets, constructing each such that it has approximately the same
number of unique genes annotated to its members as a real GO
branch (for more details see Methods). We used these random
term sets to study the application of functional enrichment
analysis methods to experimental gene signatures and to syste-
matically determine if annotation database properties might be a
source of false positives. Specifically, using both the traditional
FET and our proposed AEA, we investigated the enrichment of
experimental gene signatures in randomly constructed term sets as
well as real GO branches. We determined the number of term-
signature comparisons considered significant at several different
thresholds and present the results in Figure 6.
Surprisingly, using FET, there is almost no difference between the
number of significant comparisons made using real GO branches
and using the randomly generated term sets. This striking similarity
can be understood as follows. When calculating the significance
between two gene sets, FET assumes all genes in those sets have an
equal probability of being chosen. This is a false assumption as some
genes are actually more likely to be annotated to any given term in
GO. Just as high degree genes are more likely to be annotated to a
randomly chosen GO branch, so too are they more likely to be
annotated to a random set of GO terms. As noted previously, experi-
mental gene signatures include an abundance of genes with higher
levels of annotations. Combined together, this bias means that these
signatures are likely to be enriched in random sets of functional
categories, just because their members have more annotations over-
all. We believe this illustrates a fundamental flaw of using FET for
functional enrichment analysis, as it will predict significant associa-
tions, not because of biological signal, but as a result of a bias in
signature annotation properties.
Compared to FET, AEA finds fewer enriched pairs at each thresh-
old, but, unlike FET, finds no signatures enriched in the random term
sets, demonstrating its ability to correct for annotation biases intro-
duced from the hierarchical relationships between those terms in the
ontology. These results give us confidence that AEA is highlighting
the connections between gene sets and branches that are most likely
to be truly biologically relevant and is robust against biases intro-
duced by annotation properties. For more analysis comparing the
effects of term set properties on FET and AEA see the supplementary
material.
A quantitative approximation to annotation enrichment analysis
partially corrects for annotation bias. One significant strength of
AEA is that it makes no assumptions regarding the structure of gene-
term annotations; however, because it uses a randomization scheme
to estimate the null hypothesis, the precision of the estimated p-
values is dependent upon the number of randomizations, and each
run of the algorithm will give slightly different results. Therefore, we
sought an analytic approximation of AEA in order to overcome these
limitations.
Given that we want to estimate the significance of annotation
overlap, one logical approach is to simply count the number of
annotations made to a gene set, the number of annotations made
to a branch in GO, and the number of annotations extending
between that gene set and branch, and use the hypergeometric prob-
ability to determine the significance of this overlap.We point out that
this approach makes the false assumption that annotations are inde-
pendent, implying that a gene could be annotated to the same term
multiple times. Another more limiting problem is that, unlike AEA,
this approach erases the hierarchical organization of annotations
encoded in the GO DAG. Because of these assumptions, predictions
made under this framework will not have the reliability of the ran-
Figure 5 | Clustergrams representing enriched term-signature pairs. (a) A clustering of signatures and terms selected based on their enrichment-score
according to FET. These signatures include those reported in25,27,29,32,36–64. (b) A clustering of signatures and terms selected based on their enrichment-
score according to AEA. The signatures and terms break into several, biologically distinct units. One is associated with immune-response, and
includes signatures published in25–27,36,37,39,41,42,65,66. A second includes signatures related to cellular-differentiation published in29,44,46,48,67–72. Another cluster
includes breast cancer signatures published in53–56,58–61,63. Finally three lymphoma32,64,73 and a viral signature33 associated with proliferation are also
included. The colorscales for the p-values were chosen to give approximately the same red/green balance in each clustergram.
www.nature.com/scientificreports
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domization protocol specified by AEA; however, they can be com-
puted quickly and without the need for any randomization to gen-
erate a null hypothesis.
Acknowledging that we are making some false assumptions
regarding the structure of gene-term annotations, we propose an
analytic framework for evaluating functional enrichment which we
call Annotation Enrichment Analysis Approximation (AEA-A).
This approximation makes use of the hypergeometric probability
to calculate the significance (or p-value approximating AEA,
pa(Mgt)) of overlap between annotations made to a given gene set
and branch in the GO hierarchy. GivenMg annotations to a gene set,
Mt annotations to terms belonging to a GO branch, andMtot annota-
tions made in the GO ontology, the probability of finding Mgt or
more annotations in common between these two sets can be written
as:
pa Mgt
 
~P M§Mgt Mg ,Mt ,Mtot
 
~
Xmin Mg ,Mt½ 
i~Mgt
Mt
i
  Mtot{Mt
Mg{i
 
Mtot
Mg
  :
ð2Þ
We point out that the equation for AEA-A is equivalent to perform-
ing an FET on annotation overlap instead of gene overlap (compare
to equation 3). We tested the performance of this approximation by
determining the functional enrichment of GO terms in our randomly
generated gene sets. The results of AEA-A are uniform across varying
gene set degree (see Supplemental Figure S5), demonstrating that
AEA-A works well at eliminating annotation bias. However, the
predicted p-values are often misleadingly low due to the independ-
ence assumption. This limitation is evident in analysis performed on
the experimental signatures (Figure 6) –manymore comparisons are
deemed ‘‘significant’’ at each threshold using AEA-A than either
AEA or the traditional FET looking at gene overlap. Furthermore,
compared to AEA, the approximation is only partially able to discern
between real GO branches and random term sets. However, we note
that it does significantly outperform the traditional FET in this
regard.
This analytic approximation may be appealing to many since it is
conceptually cleaner than the randomization protocol specified by
AEA. Furthermore, since it is mathematically equivalent to the more
traditional FET analysis, it may also be simpler to implement in
current functional enrichment tools. However, although AEA-A is
conceptually appealing and has some advantages over traditional
FET, it does not provide results that are as discerning as AEA.
Therefore, we believe AEA is a better approach for analyzing func-
tional enrichment in gene sets, but provide AEA-A as an alternative
that combines many of the advantages of AEA with an analytical
form that will be easier to implement in practice.
Discussion
We have demonstrated that evaluating the functional enrichment of
gene sets using traditional set-overlap statistics, such as FET, is sus-
ceptible to producing false positives as a result of certain annotation
database properties. We offer a solution, Annotation Enrichment
Analysis, or AEA, that fully considers these properties, eliminating
potential annotation bias in the predicted enrichment scores. The
importance of using this approach is highlighted by the fact that
many published gene-signatures include a large number of highly-
annotated genes. This is likely in part due to a non-independence
between identified signatures and functional annotations, since
genes that are involved in a well-studied phenomena such as cancer
are also more likely to be frequently annotated in these databases.
Although it is possible that newly-derived gene signatures may not
exhibit the same level of annotation-bias as these previously-pub-
lished signatures, it is also very probable that highly annotated genes
are important in a wide variety of well-studied systems and will
continue to show up and influence the results of functional enrich-
ment analysis on newly generated gene sets.
The annotation-bias associated with FET results and the bias for
higher annotation-levels among experimentally-derived gene signa-
tures is largely unrecognized. Although significant p-values for func-
tional enrichment in experimental signatures may initially seem
compelling for the bioinformatician, we suggest that these results
do not always reflect biological properties but instead have a high
potential to be a result of statistical bias. In light of our analysis we
suggest using the AEA approach either alongside or in place of other
traditional measures, especially for gene signatures that are known to
contain significantly more or less annotations than one would expect
by chance. Furthermore, we urge the bioinformatics community to
consider annotation properties of gene signatures and annotation
databases before utilizing results from the wide variety of available
gene set enrichment tools. We believe that considering annotation
enrichment will allow biologists to better interpret the functional
roles of genes identified as important in their experimental system.
Methods
Calculating functional enrichment using set-overlap statistic. In this analysis we
used Fisher’s Exact Test (FET) to perform a ‘‘traditional’’ functional enrichment
analysis. FET is related to the hypergeometric probability and can be used to calculate
the significance, or p-value estimated using FET (pF(Ngt)), of the overlap between two
independent sets. For example, given a gene set containing Ng genes, a GO term with
annotations to kt different genes, andNtot total genes annotated inGO, the probability
that Ngt or more genes belong both to this gene set and are annotated to the GO term
can be calculated as:
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Figure 6 | A plot of the number of term-signature comparisons deemed ‘‘significant’’ at various p-value thresholds. A dotted line indicates only one
comparison with a p-value less than or equal to the indicated threshold, and cases where no significant comparisons were found for the corresponding p-
value are indicated by a bar not exceeding this line. Evaluations using gene annotations to GO branches are shown as solid colors, whereas evaluations
using genes annotated to random term sets are striped. AEA-A refers to the results when using a quantitative approximation to AEA.
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Note that in this equation Ng and kt are mathematically interchangeable.
Together with the FET, we also sometimes determine the False Discovery Rate
(FDR) of the tests in order to account for Type I errors (20,21). In these cases, we
calculate the FDR using the matlab function ‘‘mafdr’’ and report the associated q-
values.
Constructing biased random gene sets and random term sets. In order to
investigate potential bias due to the annotation properties, we constructed random
gene sets with the same number of members, but with varying amounts of
annotations made by those members. Each set with a desired total number of
annotations,Mg, was created by first randomly selectingNg genes. We then randomly
selected one gene in this gene set (gene i) and one gene not in the gene set (gene j). If
replacing gene i with gene j caused the total number of annotations made by genes in
the gene set to approachMg, we replaced gene i with gene j with a high probability (p
5 0.95), but if the replacement caused the average degree of the gene set to move
farther away fromMgwe replaced gene iwith gene jwith a low probability (p5 0.05).
This swapping continued until the total number of annotations made by the gene set
was within 0.1% ofMg. In this way we created 200 gene sets withNg5 200 genes each,
but whose average degree (kavg5Mg/Ng) varies from approximately 21 to 65, or from
around half to 1.5 times the expected average degree of 43 (see Figure 1).
We also constructed sets of randomGO terms. Specifically, to build a random term
set for comparison with a branch in the GO DAG, we determined the number of
annotations made to the parent term of the GO branch (kt), we then randomly
ordered all the terms in GO and selected the topNt terms until the number of unique
genes annotated to those Nt random terms kt’ð Þ was within a small percentage of
kt kt{kt’j j=ktv0:01ð Þ. In the case where selecting bothNt andNt11 terms were within
this limit we chose Nt to minimize the absolute difference between kt and kt’. If
selecting the topNt terms did not lead to a situation within this limit, we reshuffled the
terms and selected the top Nt terms in this new list, repeating until a suitable random
collection of terms could be chosen. In this way we created 10192 random term sets
with approximately the same number of unique genes annotated to each as to real GO
branches.
Clustering AEA and FET results.Hierarchical clustering of the AEA and FET results
was performed using the ‘‘clustergram’’ function in Matlab with default settings.
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